{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:14:43Z","timestamp":1768547683976,"version":"3.49.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T00:00:00Z","timestamp":1481241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009060","name":"Sidaction","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les Hepatites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD079214"],"award-info":[{"award-number":["R01HD079214"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CRP Sant\u00e9 Luxembourg"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0166466","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T14:29:26Z","timestamp":1481293766000},"page":"e0166466","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Costs of Care of HIV-Infected Children Initiating Lopinavir\/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d\u2019Ivoire"],"prefix":"10.1371","volume":"11","author":[{"given":"Sophie","family":"Desmonde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divine","family":"Avit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junie","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine","family":"Amorissani Folquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois Tanoh","family":"Eboua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarisse","family":"Amani Bosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Dainguy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Mea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marguerite","family":"Timite-Konan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Ngbech\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ciaranello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriane","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,12,9]]},"reference":[{"key":"ref1","unstructured":"World Health Organisation (2014) 2014 Progress Report On The Global Plan."},{"key":"ref2","unstructured":"World Health Organisation (2011) Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive In: UNAIDS, editor."},{"key":"ref3","unstructured":"World Health Organisation (2013) Progress report on the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. In: UNAIDS, editor."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0140-6736(04)17140-7","article-title":"Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis","volume":"364","author":"M-L Newell","year":"2004","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"A Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"ref6","unstructured":"World Health Organisation (2010) Antiretroviral Therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2010 Revision. In: UNAIDS, editor."},{"key":"ref7","article-title":"The use of antiretroviral drugs for treating and preventing HIV infection","year":"2013"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1000931","article-title":"Antiretroviral treatment for children with peripartum nevirapine exposure","volume":"363","author":"P Palumbo","year":"2010","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa1113249","article-title":"Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children","volume":"366","author":"A Violari","year":"2012","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e1001273","DOI":"10.1371\/journal.pmed.1001273","article-title":"Treatment of young children with HIV infection: using evidence to inform policymakers","volume":"9","author":"AJ Prendergast","year":"2012","journal-title":"PLoS Med"},{"issue":"Suppl 1","key":"ref11","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/01.aids.0000327621.24232.71","article-title":"Assessing efficiency and costs of scaling up HIV treatment","volume":"22","author":"SM Cleary","year":"2008","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/QAD.0b013e3283463eec","article-title":"The cost of providing comprehensive HIV treatment in PEPFAR-supported programs","volume":"25","author":"NA Menzies","year":"2011","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QAD.0b013e32835a5b92","article-title":"Cost and outcomes of paediatric antiretroviral treatment in South Africa","volume":"27","author":"G Meyer-Rath","year":"2013","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/QAD.0000000000000672","article-title":"Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age","volume":"29","author":"AL Ciaranello","year":"2015","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/QAI.0b013e318298a309","article-title":"Five-year trends in antiretroviral usage and drug costs in HIV-infected children in Thailand","volume":"64","author":"I Collins","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref16","unstructured":"Leroy V, Amorissani-Folquet M, Yonaba C, Coulibaly M, Avit D, Malateste K, et al. (2015) Efavirenz-based therapy may simplify LPV-based therapy initiated before the age of 2 in HIV-infected children not exposed to single dose NVP to Prevent Mother-to-Child Transmission (PMTCT) in West-Africa. 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention,. Vancouver, Canada."},{"key":"ref17","unstructured":"Ministere de la Sante de la Lutte contre le SIDA in Cote d'Ivoire (2012) Directives Nationales Pour Le Suivi Clinique Et Biologique De L\u2019infecton A Vih Chez L\u2019enfant (C\u00f4te d\u2019Ivoire). In: Ministere de la Sante de la Lutte contre le SIDA, editor. REPUBLIQUE DE COTE D\u2019IVOIRE."},{"key":"ref18","article-title":"The Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events","year":"2004"},{"key":"ref19","unstructured":"Yonaba C, Deschamps N, Eboua F, Desmonde S, Mea V, Ouedraogo S, et al. (2015) Severe morbidity in HIV-infected children before and after initiating lopinavir-based therapy before the age of two in West Africa, 2011\u20132014. 7th International Workshop on HIV Pediatric. Vancouver, Canada."},{"key":"ref20","unstructured":"World Health Organisation (2009) CHOosing interventions that are cost-effective (WHO-CHOICE): Cost-effectiveness thresholds.Geneva."},{"key":"ref21","unstructured":"Initiative CHA (2012) Antiretroviral (ARV) ceiling prist list."},{"key":"ref22","unstructured":"Central Intelligence Agency (2013) The world factbook."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/QAD.0000000000000518","article-title":"Opportunities for improving the efficiency of paediatric HIV treatment programmes","volume":"29","author":"PA Revill","year":"2015","journal-title":"Aids"},{"key":"ref24","unstructured":"World Health Organisation Global Price Reporting Mechanism for HIV, Tuberculosis and Malaria."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12879-015-0952-6","article-title":"Prevalence of malnutrition among HIV-infected children in Central and West-African HIV-care programmes supported by the Growing Up Programme in 2011: a cross-sectional study","volume":"15","author":"J Jesson","year":"2015","journal-title":"BMC Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1097\/INF.0000000000000734","article-title":"Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort","volume":"34","author":"J Jesson","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/QAD.0b013e32834171db","article-title":"Younger age at HAART initiation is associated with more rapid growth reconstitution","volume":"25","author":"CJ McGrath","year":"2011","journal-title":"AIDS (London, England)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2471\/BLT.09.068015","article-title":"Scaling up antiretroviral therapy for HIV-infected children in C\u00f4te d'Ivoire: determinants of survival and loss to programme","volume":"88","author":"MF Anaky","year":"2010","journal-title":"Bull World Health Organ"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1097\/QAI.0b013e3182a4ea6f","article-title":"Morbidity and health care resource utilization in HIV-infected children after antiretroviral therapy initiation in Cote d'Ivoire, 2004\u20132009","volume":"65","author":"S Desmonde","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/INF.0b013e318278b222","article-title":"Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count","volume":"32","author":"PD Beaudrap","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"ref31","unstructured":"The World Bank, World Development Indicators (2012) GNI per capita, Atlas method"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-151-3-200908040-00138","article-title":"When to start antiretroviral therapy in resource-limited settings","volume":"151","author":"RP Walensky","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref33","first-page":"1141","article-title":"Cost-Effectiveness of HIV Treatment in Resource-Poor Settings\u2014The Case of C\u00f4te d\u2019Ivoire","author":"E Losina","year":"2006","journal-title":"Baseline"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJMsa060247","article-title":"Cost-effectiveness of HIV treatment in resource-poor settings\u2014the case of Cote d'Ivoire","volume":"355","author":"SJ Goldie","year":"2006","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.298.16.1888","article-title":"Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia","volume":"298","author":"C Bolton-Moore","year":"2007","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1365-3156.2009.02360.x","article-title":"Causes of morbidity among HIV-infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia","volume":"14","author":"M Mubiana-Mbewe","year":"2009","journal-title":"Trop Med Int Health"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/tropej\/fmn106","article-title":"Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000\u201304","volume":"55","author":"C Walenda","year":"2009","journal-title":"J Trop Pediatr"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/QAI.0b013e3182739c95","article-title":"Health care resource utilization in untreated HIV-infected children in a pediatric programme, Abidjan, Cote d'Ivoire, 2004\u20132009","volume":"62","author":"S Desmonde","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref39","article-title":"Within-trial costing and cost-effectiveness analyses of clinically\u2014driven versus laboratory and clinical monitoring for 1206 African children on ART in the ARROW trial","author":"P Revill","year":"2013"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1472-6963-14-201","article-title":"Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations","volume":"14","author":"K Doherty","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e1000189","DOI":"10.1371\/journal.pmed.1000189","article-title":"Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis","volume":"6","author":"R Leisegang","year":"2009","journal-title":"PLoS medicine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.qai.0000191286.70331.7b","article-title":"Updated estimates of healthcare utilization and costs among perinatally HIV-infected children","volume":"41","author":"SL Sansom","year":"2006","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0166466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T23:38:53Z","timestamp":1540251533000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0166466"}},"subtitle":[],"editor":[{"given":"Carlo Federico","family":"Perno","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,9]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0166466","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,9]]}}}